Sanda, Japan

Hisao Minato

This inventor holds 1 USPTO granted patent. Top assignee: Dainippon Pharmaceutical Company, Limited. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hisao Minato. Retrieved from https://idiyas.com/inventor/hisao-minato

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hisao Minato: Innovator in Blood Lipid Metabolism

Introduction

Hisao Minato is a notable inventor based in Sanda, Japan. He has made significant contributions to the field of medical science, particularly in the area of blood lipid metabolism. His work has implications for improving health outcomes related to lipid levels in the blood.

Latest Patents

Hisao Minato holds a patent for an "Ameliorant for blood lipid metabolism." This invention aims to enhance the management of blood lipid levels, which is crucial for preventing cardiovascular diseases and promoting overall health. He has 1 patent to his name, showcasing his innovative approach to addressing health issues.

Career Highlights

Minato is currently employed at Dainippon Pharmaceutical Company, Limited, where he continues to engage in research and development. His role at this esteemed pharmaceutical company allows him to contribute to advancements in medical treatments and therapies.

Collaborations

Throughout his career, Minato has collaborated with talented individuals such as Akihisa Ikeno and Kanoo Hosoki. These collaborations have likely enriched his research and led to further innovations in the field.

Conclusion

Hisao Minato's work in blood lipid metabolism exemplifies the impact of innovative thinking in healthcare. His contributions are vital for advancing medical science and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…